Search

Emu (Dromaius novaehollandiae) is the second largest avian species in the world and is native to Australia. Emus are classified as ratites along with South African ostriches and South American rheas and are becoming popular as a source of low-fat, low-cholesterol, iron-rich red meat alternative. Emu meat has also been touted as a good source of protein, B vitamins, and creatine. In addition to its meat, emu oil has received attention for its possible therapeutic use, notably anti-inflamatory, and cosmetic benefits. However, the emu industry is very young, with already standardized hatching, feeding, rearing, and other management practices leading to the availability of a large number of grown-up birds. Hence, the emu industry is looking for science-based information in order to successfully produce and market emu meat, fat, skin, and feathers. The present review was prepared to provide information regarding emu slaughter, meat quality, composition, nutritional benefits, sensory attributes, comparison of emu meat over existing traditional meats, and emu fat and its potential therapeutic applications. [ABSTRACT FROM PUBLISHER]

• A review was undertaken of an Australia-wide ambulatory video-EEG monitoring service. • Patients were in view of camera for 94.90% of events, and 84.89% of studies had all events on camera. • 84.42% of events from wakefulness were reported, compared to 54.27% from sleep. Recording electrographic and behavioral information during epileptic and other paroxysmal events is important during video electroencephalography (EEG) monitoring. This study was undertaken to measure the event capture rate of an home service operating across Australia using a shoulder-worn EEG device and telescopic pole-mounted camera. Neurologist reports were accessed retrospectively. Studies with confirmed events were identified and assessed for event capture by recording modality, whether events were reported or discovered, and physiological state. 6,265 studies were identified, of which 2,788 (44.50%) had events. A total of 15,691 events were captured, of which 77.89% were reported. The EEG amplifier was active for 99.83% of events. The patient was in view of the camera for 94.90% of events. 84.89% of studies had all events on camera, and 2.65% had zero events on camera (mean = 93.66%, median = 100.00%). 84.42% of events from wakefulness were reported, compared to 54.27% from sleep. Event capture was similar to previously reported rates from home studies, with higher capture rates on video. Most patients have all events captured on camera. Home monitoring is capable of high rates of event capture, and the use of wide-angle cameras allows for all events to be captured in the majority of studies. [ABSTRACT FROM AUTHOR]